HEALTHCARE

Market Overview: The global market for artificial pancreas device system, as described by Market Research Future (MRFR), is showing potential of achieving almost 21.10% CAGR during the forecast period of 2018 to 2023 . In the process, the market is showing promising signs of crossing USD 341.08 million by the end of 2023. In case of type 1 and type 2 diabetes, the pancreas produces little to no insulin which makes it imperative for patients, especially those suffering from type 1diabetes, to inject insulin to regulate their blood glucose levels. This is important to keep complications such as cardiovascular disease, kidney failure, blindness etc. at bay. However, diabetes management involves blood glucose monitoring, insulin dose calculation and insulin infusion with needle or pump. The use of an artificial pancreas device system which continuously monitors blood glucose is often found to be beneficial for many patients. Healthcare regulatory bodies like the U.S. FDA are closely c...

Market Overview: The global market for artificial pancreas device system, as described by Market Research Future (MRFR), is showing potential of achieving almost 21.10% CAGR during the forecast period of 2018 to 2023. In the process, the market is showing promising signs of crossing USD 341.08 million by the end of 2023. The market for artificial pancreas device system is banking on the incorporation of the technology to counter growing occurrences of diabetes related diseases. The Artificial Pancreas Device System Market is banking on technological support from the latest innovations, continuous rise in investment, better integration of innovations in the system, rising availability of skilled hands to support such processes, growing expenditure capacity, and others can impact the market for artificial pancreas device system. Growing awareness regarding diseases triggering the intake of the process can influence market growth. Competitive Landscape: ·    ...